13 Steven Cohen Arcutis Biotherapeutics Trades
The first Arcutis Biotherapeutics trade was made in Q3 2020. Since then Steven Cohen bought shares seven more times and sold shares on five occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Arcutis Biotherapeutics anymore.
Avg closing price
Price range
Sold -320 Thousand shares
Q1 2024
Avg closing price
$7.46
Price range
$3.25
-
$11.77
New holding (+320 Thousand shares)
Q4 2023
Avg closing price
$2.72
Price range
$1.84
-
$4.82
Sold -1.1 Million shares
Q1 2023
Avg closing price
$14.47
Price range
$10.23
-
$17.14
Sold 70.8% shares (-2.68 Million shares)
Q4 2022
Avg closing price
$17.47
Price range
$13.96
-
$20.40
Increased shares by 90.5% (+1.8 Million shares)
Q3 2022
Avg closing price
$22.66
Price range
$17.85
-
$26.95
Increased shares by 17.1% (+290 Thousand shares)
Q2 2022
Avg closing price
$20.51
Price range
$16.33
-
$22.20
Sold 35.8% shares (-946 Thousand shares)
Q1 2022
Avg closing price
$16.92
Price range
$14.38
-
$22.79
Increased shares by 32.7% (+652 Thousand shares)
Q4 2021
Avg closing price
$19.90
Price range
$14.98
-
$25.50
Increased shares by 122.2% (+1.1 Million shares)
Q3 2021
Avg closing price
$22.81
Price range
$19.28
-
$27.10
Increased shares by 104.1% (+457 Thousand shares)
Q2 2021
Avg closing price
$28.17
Price range
$24.42
-
$34.75
Sold 49.8% shares (-436 Thousand shares)
Q1 2021
Avg closing price
$31.23
Price range
$24.47
-
$36.98
Increased shares by 1923.3% (+832 Thousand shares)
Q4 2020
Avg closing price
$24.49
Price range
$17.82
-
$31.73
New holding (+43.3 Thousand shares)
Q3 2020
Avg closing price
$26.72
Price range
$23.44
-
$32.28
